ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-12P3311
Home | Market Reports | Health| Pharmacy
Global Influenza Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Influenza Drugs Market Research Report 2025

Code: QYRE-Auto-12P3311
Report
September 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Astrazeneca plc
Eli Lilly
Roche
GlaxoSmithKline PLC
Novartis
Pfizer Inc
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen

Influenza Drugs Market Size

The global market for Influenza Drugs was valued at US$ 1823 million in the year 2024 and is projected to reach a revised size of US$ 2281 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Influenza Drugs Market

Influenza Drugs Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Influenza Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Drugs.
The Influenza Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Influenza Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Influenza Drugs Market Report

Report Metric Details
Report Name Influenza Drugs Market
Accounted market size in year US$ 1823 million
Forecasted market size in 2031 US$ 2281 million
CAGR 3.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Zanamivir
  • Oseltamivir Phosphate
  • Peramivir
  • Other Influenza Drugs
Segment by Application
  • Adults
  • Chidren
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bristol-Myers Squibb], AstraZeneca, Eli Lilly, Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur, Bayer, Celgene, Seqirus, Protein Sciences Corporation, Serum Institute of India, Emergent Biosolutions, BioCryst Pharmaceuticals, Alvogen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Influenza Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Influenza Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Influenza Drugs Market growing?

Ans: The Influenza Drugs Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Influenza Drugs Market size in 2031?

Ans: The Influenza Drugs Market size in 2031 will be US$ 2281 million.

Who are the main players in the Influenza Drugs Market report?

Ans: The main players in the Influenza Drugs Market are Bristol-Myers Squibb], AstraZeneca, Eli Lilly, Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur, Bayer, Celgene, Seqirus, Protein Sciences Corporation, Serum Institute of India, Emergent Biosolutions, BioCryst Pharmaceuticals, Alvogen

What are the Application segmentation covered in the Influenza Drugs Market report?

Ans: The Applications covered in the Influenza Drugs Market report are Adults, Chidren

What are the Type segmentation covered in the Influenza Drugs Market report?

Ans: The Types covered in the Influenza Drugs Market report are Zanamivir, Oseltamivir Phosphate, Peramivir, Other Influenza Drugs

1 Influenza Drugs Market Overview
1.1 Product Definition
1.2 Influenza Drugs by Type
1.2.1 Global Influenza Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Zanamivir
1.2.3 Oseltamivir Phosphate
1.2.4 Peramivir
1.2.5 Other Influenza Drugs
1.3 Influenza Drugs by Application
1.3.1 Global Influenza Drugs Market Value by Application (2024 VS 2031)
1.3.2 Adults
1.3.3 Chidren
1.4 Global Influenza Drugs Market Size Estimates and Forecasts
1.4.1 Global Influenza Drugs Revenue 2020-2031
1.4.2 Global Influenza Drugs Sales 2020-2031
1.4.3 Global Influenza Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Influenza Drugs Market Competition by Manufacturers
2.1 Global Influenza Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Influenza Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Influenza Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Influenza Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Influenza Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Influenza Drugs, Product Type & Application
2.7 Global Key Manufacturers of Influenza Drugs, Date of Enter into This Industry
2.8 Global Influenza Drugs Market Competitive Situation and Trends
2.8.1 Global Influenza Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Influenza Drugs Players Market Share by Revenue
2.8.3 Global Influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Influenza Drugs Market Scenario by Region
3.1 Global Influenza Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Influenza Drugs Sales by Region: 2020-2031
3.2.1 Global Influenza Drugs Sales by Region: 2020-2025
3.2.2 Global Influenza Drugs Sales by Region: 2026-2031
3.3 Global Influenza Drugs Revenue by Region: 2020-2031
3.3.1 Global Influenza Drugs Revenue by Region: 2020-2025
3.3.2 Global Influenza Drugs Revenue by Region: 2026-2031
3.4 North America Influenza Drugs Market Facts & Figures by Country
3.4.1 North America Influenza Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Influenza Drugs Sales by Country (2020-2031)
3.4.3 North America Influenza Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Influenza Drugs Market Facts & Figures by Country
3.5.1 Europe Influenza Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Influenza Drugs Sales by Country (2020-2031)
3.5.3 Europe Influenza Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Influenza Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Influenza Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Influenza Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Influenza Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Influenza Drugs Market Facts & Figures by Country
3.7.1 Latin America Influenza Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Influenza Drugs Sales by Country (2020-2031)
3.7.3 Latin America Influenza Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Influenza Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Influenza Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Influenza Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Influenza Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Influenza Drugs Sales by Type (2020-2031)
4.1.1 Global Influenza Drugs Sales by Type (2020-2025)
4.1.2 Global Influenza Drugs Sales by Type (2026-2031)
4.1.3 Global Influenza Drugs Sales Market Share by Type (2020-2031)
4.2 Global Influenza Drugs Revenue by Type (2020-2031)
4.2.1 Global Influenza Drugs Revenue by Type (2020-2025)
4.2.2 Global Influenza Drugs Revenue by Type (2026-2031)
4.2.3 Global Influenza Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Influenza Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Influenza Drugs Sales by Application (2020-2031)
5.1.1 Global Influenza Drugs Sales by Application (2020-2025)
5.1.2 Global Influenza Drugs Sales by Application (2026-2031)
5.1.3 Global Influenza Drugs Sales Market Share by Application (2020-2031)
5.2 Global Influenza Drugs Revenue by Application (2020-2031)
5.2.1 Global Influenza Drugs Revenue by Application (2020-2025)
5.2.2 Global Influenza Drugs Revenue by Application (2026-2031)
5.2.3 Global Influenza Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Influenza Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Company Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bristol-Myers Squibb Influenza Drugs Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca Influenza Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Influenza Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Roche
6.4.1 Roche Company Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Roche Influenza Drugs Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Company Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKline Influenza Drugs Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Influenza Drugs Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Influenza Drugs Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Sanofi Pasteur
6.8.1 Sanofi Pasteur Company Information
6.8.2 Sanofi Pasteur Description and Business Overview
6.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi Pasteur Influenza Drugs Product Portfolio
6.8.5 Sanofi Pasteur Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Influenza Drugs Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Celgene
6.10.1 Celgene Company Information
6.10.2 Celgene Description and Business Overview
6.10.3 Celgene Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Celgene Influenza Drugs Product Portfolio
6.10.5 Celgene Recent Developments/Updates
6.11 Seqirus
6.11.1 Seqirus Company Information
6.11.2 Seqirus Description and Business Overview
6.11.3 Seqirus Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Seqirus Influenza Drugs Product Portfolio
6.11.5 Seqirus Recent Developments/Updates
6.12 Protein Sciences Corporation
6.12.1 Protein Sciences Corporation Company Information
6.12.2 Protein Sciences Corporation Description and Business Overview
6.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Protein Sciences Corporation Influenza Drugs Product Portfolio
6.12.5 Protein Sciences Corporation Recent Developments/Updates
6.13 Serum Institute of India
6.13.1 Serum Institute of India Company Information
6.13.2 Serum Institute of India Description and Business Overview
6.13.3 Serum Institute of India Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Serum Institute of India Influenza Drugs Product Portfolio
6.13.5 Serum Institute of India Recent Developments/Updates
6.14 Emergent Biosolutions
6.14.1 Emergent Biosolutions Company Information
6.14.2 Emergent Biosolutions Description and Business Overview
6.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Emergent Biosolutions Influenza Drugs Product Portfolio
6.14.5 Emergent Biosolutions Recent Developments/Updates
6.15 BioCryst Pharmaceuticals
6.15.1 BioCryst Pharmaceuticals Company Information
6.15.2 BioCryst Pharmaceuticals Description and Business Overview
6.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 BioCryst Pharmaceuticals Influenza Drugs Product Portfolio
6.15.5 BioCryst Pharmaceuticals Recent Developments/Updates
6.16 Alvogen
6.16.1 Alvogen Company Information
6.16.2 Alvogen Description and Business Overview
6.16.3 Alvogen Influenza Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Alvogen Influenza Drugs Product Portfolio
6.16.5 Alvogen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Influenza Drugs Industry Chain Analysis
7.2 Influenza Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Influenza Drugs Production Mode & Process Analysis
7.4 Influenza Drugs Sales and Marketing
7.4.1 Influenza Drugs Sales Channels
7.4.2 Influenza Drugs Distributors
7.5 Influenza Drugs Customer Analysis
8 Influenza Drugs Market Dynamics
8.1 Influenza Drugs Industry Trends
8.2 Influenza Drugs Market Drivers
8.3 Influenza Drugs Market Challenges
8.4 Influenza Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
Astrazeneca plc
Eli Lilly
Roche
GlaxoSmithKline PLC
Novartis
Pfizer Inc
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
List of Tables
 Table 1. Global Influenza Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Influenza Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Influenza Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Influenza Drugs Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Influenza Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Influenza Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Influenza Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Influenza Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Influenza Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Influenza Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Influenza Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Influenza Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Influenza Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Influenza Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Influenza Drugs Sales by Region (2020-2025) & (K MT)
 Table 18. Global Influenza Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Influenza Drugs Sales by Region (2026-2031) & (K MT)
 Table 20. Global Influenza Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Influenza Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Influenza Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Influenza Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Influenza Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Influenza Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Influenza Drugs Sales by Country (2020-2025) & (K MT)
 Table 27. North America Influenza Drugs Sales by Country (2026-2031) & (K MT)
 Table 28. North America Influenza Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Influenza Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Influenza Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Influenza Drugs Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Influenza Drugs Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Influenza Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Influenza Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Influenza Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Influenza Drugs Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Influenza Drugs Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Influenza Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Influenza Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Influenza Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Influenza Drugs Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Influenza Drugs Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Influenza Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Influenza Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Influenza Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Influenza Drugs Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Influenza Drugs Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Influenza Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Influenza Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Influenza Drugs Sales (K MT) by Type (2020-2025)
 Table 51. Global Influenza Drugs Sales (K MT) by Type (2026-2031)
 Table 52. Global Influenza Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Influenza Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Influenza Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Influenza Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Influenza Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Influenza Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Influenza Drugs Price (USD/MT) by Type (2020-2025)
 Table 59. Global Influenza Drugs Price (USD/MT) by Type (2026-2031)
 Table 60. Global Influenza Drugs Sales (K MT) by Application (2020-2025)
 Table 61. Global Influenza Drugs Sales (K MT) by Application (2026-2031)
 Table 62. Global Influenza Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Influenza Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Influenza Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Influenza Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Influenza Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Influenza Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Influenza Drugs Price (USD/MT) by Application (2020-2025)
 Table 69. Global Influenza Drugs Price (USD/MT) by Application (2026-2031)
 Table 70. Bristol-Myers Squibb Company Information
 Table 71. Bristol-Myers Squibb Description and Business Overview
 Table 72. Bristol-Myers Squibb Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Bristol-Myers Squibb Influenza Drugs Product
 Table 74. Bristol-Myers Squibb Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. AstraZeneca Influenza Drugs Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Eli Lilly Company Information
 Table 81. Eli Lilly Description and Business Overview
 Table 82. Eli Lilly Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Eli Lilly Influenza Drugs Product
 Table 84. Eli Lilly Recent Developments/Updates
 Table 85. Roche Company Information
 Table 86. Roche Description and Business Overview
 Table 87. Roche Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Roche Influenza Drugs Product
 Table 89. Roche Recent Developments/Updates
 Table 90. GlaxoSmithKline Company Information
 Table 91. GlaxoSmithKline Description and Business Overview
 Table 92. GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. GlaxoSmithKline Influenza Drugs Product
 Table 94. GlaxoSmithKline Recent Developments/Updates
 Table 95. Novartis Company Information
 Table 96. Novartis Description and Business Overview
 Table 97. Novartis Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Novartis Influenza Drugs Product
 Table 99. Novartis Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Pfizer Influenza Drugs Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. Sanofi Pasteur Company Information
 Table 106. Sanofi Pasteur Description and Business Overview
 Table 107. Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Sanofi Pasteur Influenza Drugs Product
 Table 109. Sanofi Pasteur Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Bayer Influenza Drugs Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. Celgene Company Information
 Table 116. Celgene Description and Business Overview
 Table 117. Celgene Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. Celgene Influenza Drugs Product
 Table 119. Celgene Recent Developments/Updates
 Table 120. Seqirus Company Information
 Table 121. Seqirus Description and Business Overview
 Table 122. Seqirus Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Seqirus Influenza Drugs Product
 Table 124. Seqirus Recent Developments/Updates
 Table 125. Protein Sciences Corporation Company Information
 Table 126. Protein Sciences Corporation Description and Business Overview
 Table 127. Protein Sciences Corporation Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 128. Protein Sciences Corporation Influenza Drugs Product
 Table 129. Protein Sciences Corporation Recent Developments/Updates
 Table 130. Serum Institute of India Company Information
 Table 131. Serum Institute of India Description and Business Overview
 Table 132. Serum Institute of India Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 133. Serum Institute of India Influenza Drugs Product
 Table 134. Serum Institute of India Recent Developments/Updates
 Table 135. Emergent Biosolutions Company Information
 Table 136. Emergent Biosolutions Description and Business Overview
 Table 137. Emergent Biosolutions Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 138. Emergent Biosolutions Influenza Drugs Product
 Table 139. Emergent Biosolutions Recent Developments/Updates
 Table 140. BioCryst Pharmaceuticals Company Information
 Table 141. BioCryst Pharmaceuticals Description and Business Overview
 Table 142. BioCryst Pharmaceuticals Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 143. BioCryst Pharmaceuticals Influenza Drugs Product
 Table 144. BioCryst Pharmaceuticals Recent Developments/Updates
 Table 145. Alvogen Company Information
 Table 146. Alvogen Description and Business Overview
 Table 147. Alvogen Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 148. Alvogen Influenza Drugs Product
 Table 149. Alvogen Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Influenza Drugs Distributors List
 Table 153. Influenza Drugs Customers List
 Table 154. Influenza Drugs Market Trends
 Table 155. Influenza Drugs Market Drivers
 Table 156. Influenza Drugs Market Challenges
 Table 157. Influenza Drugs Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Influenza Drugs
 Figure 2. Global Influenza Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Influenza Drugs Market Share by Type: 2024 & 2031
 Figure 4. Zanamivir Product Picture
 Figure 5. Oseltamivir Phosphate Product Picture
 Figure 6. Peramivir Product Picture
 Figure 7. Other Influenza Drugs Product Picture
 Figure 8. Global Influenza Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Influenza Drugs Market Share by Application: 2024 & 2031
 Figure 10. Adults
 Figure 11. Chidren
 Figure 12. Global Influenza Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Influenza Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Influenza Drugs Sales (2020-2031) & (K MT)
 Figure 15. Global Influenza Drugs Average Price (USD/MT) & (2020-2031)
 Figure 16. Influenza Drugs Report Years Considered
 Figure 17. Influenza Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Influenza Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Influenza Drugs Players: Market Share by Revenue in Influenza Drugs in 2024
 Figure 20. Influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Influenza Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Influenza Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Influenza Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Influenza Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Influenza Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Influenza Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Influenza Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Influenza Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Influenza Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Influenza Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Influenza Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Influenza Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Influenza Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Influenza Drugs by Type (2020-2031)
 Figure 57. Global Influenza Drugs Price (USD/MT) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Influenza Drugs by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Influenza Drugs by Application (2020-2031)
 Figure 60. Global Influenza Drugs Price (USD/MT) by Application (2020-2031)
 Figure 61. Influenza Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Influenza Drugs and Vaccines Market Research Report 2025
Influenza Antiviral Drugs Market
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Trivalent Flu Vaccine Market Insights Forecast to 2030
Global Quadrivalent Flu Vaccine Market Insights Forecast to 2030
Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inactivated Influenza Vaccine Market
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Insomnia Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Digital Data Logger Market Insights Forecast to 2030
Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Asset Managements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Infectives Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions